FDA:Expansion of the Abbreviated 510(k) 2 Program


Quite Involved in Discussions
"The draft guidance provides details on which devices would be considered appropriate for the new option based on intended use and technological characteristics, how FDA intends to identify performance criteria for the purposes of making final substantial equivalence determinations, as well as what the expectations are for device makers submitting data for FDA review via this program.

For example, the agency said it “expects a submitter to demonstrate that the new device meets the FDA-identified performance criteria by submitting a declaration of conformity, a summary of the data, and/or underlying data, as appropriate.”


Top Bottom